Cough, wheezing, and rash in a patient with a history of allergic bronchopulmonary aspergillosis

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 4, 2005, Pages 439-444

  Haque, Farah N ^a   Kaplan, Jennifer ^a   Fried, Marianne ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; METHYLPREDNISOLONE; PREDNISONE; SALBUTAMOL; TRIAMCINOLONE;

ADULT; BRONCHOPULMONARY ASPERGILLOMA; CASE REPORT; CLINICAL FEATURE; COUGHING; DISEASE COURSE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; PAPULAR SKIN DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; REVIEW; SPIROMETRY; WHEEZING;

EID: 17444423216     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61113-1     Document Type: Article

References (51)

1. Lemanske RF, Busse WW. Asthma. J Allergy Clin Immunol. 2003;111:S502-S519.
2. National Asthma Education and Prevention Program Expert Panel. Guidelines for the diagnosis and management of asthma: update on selected topics, 2002. J Allergy Clinical Immunol. 2002;110(suppl):S141-S219.
3. Jarjour NN, Kelly EA. Pathogenesis of asthma. Med Clin North Am. 2002;86:925-936.
4. Dela Fuente G, Moll B, Raju L, Lin J, Frieri M. Immunohistologic analysis in autopsy specimens from asthma patients. J Allergy Clin Immunol. 1997;99:1679a.
5. Frieri M. Allergen and environmental triggers. Emerg Med. 1999;31:73-78.
6. Martinez FD, Wright AL, Taussing LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-138.
7. Robinson DS. Th-2 cytokines in allergic disease. Br Med Bull. 2000;16:1008-1015.
8. Galli SJ. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med. 1997;186:343-347.
9. Leyko B, Huang YC, Frieri M. Assessment of RANTES mRNA production and expression in respiratory syncytial virus (RSV) antigen-stimulated and IL-1β stimulated A549 cells: inhibition via montelukast and budesonide. Ann Allergy Immunol. 2004;92:53a.
10. Home NS, Huang YC, Frieri M. Modulation of IL-8 mRNA expression and production in respiratory syncytial virus (RSV) stimulated human alveolar epithelial cells by budesonide and montelukast. J Allergy Clin Immunol. 2004;113:S192.
11. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202-1218.
12. Frieri M. New frontiers in immunotherapy. Allergy Asthma Proc. 1999;20:281-288.
13. Milgrom H, Pick RB Jr, Su JQ, et al; RhuMAb-E25 Study Group. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med. 1999;341:1966-1973.
14. Greenberger PA. Allergic bronchopulmonary aspergillosis: current reviews of allergy and clinical immunology. J Allergy Clin Immunol. 2002;110:685-692.
15. Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med. 1982;96:286-291.
16. Murali PS, Kurup VP, Bansal NK, et al. IgE downregulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. J Lab Clin Med. 1998;131:228-235.
17. Schuyler M. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med. 1998;131:194-196.
18. Leon EE, Craig TJ. Antifungals in the treatment of ABPA. Ann Allergy Asthma Immunol. 1999;82:511-517.
19. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med. 1995;152(4 pt 1):1379-1381.
20. Christopher KL, Wood RP II, Eckeit RC et al. Vocal cord dysfunction presenting as asthma. N Engl J Med. 1998;308:1566-1570.
21. Kauppinan K, Stubb S. Drug eruptions: causative agents and clinical types. Acta Derm Venereol (Stockh). 1984;64:320-324.
22. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol. 1983;8:763-775.
23. Leavitt RY. Cutaneous vasculitis. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology and Rheumatology. 4th ed. St Louis, MO: Mosby; 1992:216-217.
24. Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 2003;4:21-29.
25. Storrs FJ. Contact dermatitis caused by drugs. Immunol Allergy Clin North Am. 1991;11:509-523.
26. Menne T, Veien NK, Maibach HI. Systemic contact-type dermatitis due to drugs. Semin Dermatol. 1989;8:144-148.
27. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Clin Immunol. 1989;84:66-71.
28. Kaplan AP, Finn A. Autoimmunity and the etiology of chronic urticaria. Can J Allergy Clin Immunol. 1999;4:286-292.
29. Bork K, Barnstedt S, Koch P, Traupe H. Hereditary angioedema with normal C-1 inhibitor activity in women. Lancet. 2000;356:213-217.
30. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor heated C1 inhibitor concentrate. N Engl J Med. 1996;334:1630-1634.
31. Slavin RG. Asthma and sinusitis. J Allergy Clin Immunol. 1992;90:534-537.
32. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 2000;106:S201-S205.
33. Bresciani M, Paradis L, Des RA, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107:73-80.
34. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J. 1998;12:1209-1218.
35. ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol. 2002;109:621-626.
36. Spahn JD, Kamada AK, Szefler SJ. Glucocorticoid therapy in asthma. In: Liberman P, Anderson JA, eds. Allergic Diseases: Diagnosis and Treatment. Totowa, NJ: Humana Press Inc; 1997:331-350.
37. Schwartz HJ, Lowell FC, Melby JC. Steroid resistance in bronchial asthma. Ann Intern Med. 1968;69:493-499.
38. Carmichael J, Paterson IC, Diaz P, Crompton GK. Corticosteroid resistance in chronic asthma. BMJ. 1981;282:1419-1422.
39. Frieri M. Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc. 1999;20:147-159.
40. Robinson D, Hamid Q, Ying S. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis. 1993;148:401-406.
41. Sher ER, Leung DYM, Surs W, Kam JC, Szefler SJ. Steroid resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest. 1994;93:33-39.
42. Spahn JD, Landwehr LP, Nimmagada S, Surs W, Szefler SJ. Effects of glucocorticoids on lymphocyte activation in patients with steroid resistant and steroid sensitive asthma. J Allergy Clin Immunol. 1996;98(6 pt 1):1073-1079.
43. National Asthma Education Program Report of the Working Group on Asthma and Pregnancy: Management of Asthma During Pregnancy. Bethesda, MD: National Heart, Lung, and Blood Institute; 1993. NIH publication 93-3279A.
44. Schatz M, Dombrowski MP, Wise R, et al. Asthma morbidity during pregnancy can be predicted by severity classification. J Allergy Clin Immunol. 2003;112:283-288.
45. Juniper EF, Newhouse MT. Effect of pregnancy on asthma: a critical appraisal of the literature. In: Schatz M, Zeiger RS, eds. Asthma and Allergy in Pregnancy and Early Infancy. New York, NY: Marcel Dekker; 1993:223-249.
46. Dombrowski MP. Pharmacologic therapy of asthma during pregnancy. Obstet Gynecol Clin North Am. 1997;24:559-574.
47. Nolten W, Rueckert P. Elevated free cortisol index in pregnancy: possible regulatory mechanisms in pregnancy. Am J Obstet Gynecol. 1981;139:492-498.
48. Schatz M, Hoffman C. Interrelationship between asthma and pregnancy: clinical and mechanistic considerations. Clin Rev Allergy. 1987;5:301-315.
49. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 3rd ed. Baltimore, MD: Williams & Wilkins; 1990:237-238, 520-521.
50. Stenius-Aarniala BS, Teramo PK. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax. 1988;43:12-18.
51. Frieri M. Management of asthma in women. Womens Health Primary Care. 2004;7:408-413.